Join to access to all OVN content. Join for Free
Repackage what you have for what you want
MSL career transition MSL capability continuum post-pandemic MSL landscape MSL digital proficiency MSL certification programs

Repackage what you have for what you want


Share This Article


Summary

In this episode, Cherie Hyder shares her journey from the FDA to the industry, discussing the transition and how to enhance skills for a successful MSL career. She emphasizes the importance of documenting experience and understanding the MSL role, highlighting the MSL capability continuum and certification programs. Cherie discusses the significance of soft skills and digital proficiency, along with predictions for the post-pandemic MSL landscape. She offers insights into effective email communication, evolving metrics, and the critical role of insight gathering. The episode wraps up with best practices for post-meeting note-taking and career development strategies.

Check out my latest podcast with Cherie Hyder, Medical Excellence at Biohaven who discusses how to repackage what you have for what you want.

Cherie shares…. 

 How to position yourself for MSL roles

 Tool and resources to be aware of

 How to showcase important skills and traits

 Certification programs and if they are worth it

 Mandatory skills for the MSL of the future

Click for Source
MSL career transition, MSL capability continuum, post-pandemic MSL landscape, MSL digital proficiency, MSL certification programs

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Podcast
Mastering the Medical Affairs Professional Role: Inside and Out
Partner Avatar MSL Talk: Tom Caravela, Kent Christofferson

Mastering the Medical Affairs Professional Role: Inside and Out

Podcast
Landing My First MSL Role: From the Inside
Partner Avatar MSL Talk: Tom Caravela, Amanda Vaughn

Landing My First MSL Role: From the Inside

Article
Virtual Clinical Trials in Oncology-Overview, Challenges, Policy Considerations, and Future Directions
OVN Avatar Kushal T. Kadakia, MSc, Malke Asaad, MD, Erica Adlakha, MS, Michael J. Overman, MD, Cristina M. Checka, MD, and Anaeze C. Offodile II, MD, MPH

Virtual Clinical Trials in Oncology-Overview, Challenges, Policy Considerations, and Future Directions

Article
Comparative study on anticancer drug access times between FDA, EMA and the French temporary authorisation for use program over 13 years
OVN Avatar Emmanuelle Jacqueta, Ghania Kerouani-Lafayeb, Francoise Grudeb, Sergio Goncalvesb, Annie Lorenced, Florence Turcryb, Liora Brunelb, Laetitia Belgodereb, Adrien Monardc, Gaëlle Guyaderb, Lotfi Boudalib, Nicolas Albin

Comparative study on anticancer drug access times between FDA, EMA and the French temporary authorisation for use program over 13 years

Article
Evaluation of Trials Comparing Single-Enantiomer Drugs to Their Racemic Precursors: A Systematic Review
OVN Avatar Aaron S. Long, BS; Audrey D. Zhang, MD; Caitlin E. Meyer, MLIS; Alexander C. Egilman, BS; Joseph S. Ross, MD, MHS; Joshua D. Wallach, PhD, MS

Evaluation of Trials Comparing Single-Enantiomer Drugs to Their Racemic Precursors: A Systematic Review

Article
Transforming oncology: Five frontiers driving progress in cancer care
Partner Avatar iNIZIO

Transforming oncology: Five frontiers driving progress in cancer care

Explore OVN